 ROCHESTER, NY ACCESSWIRE August 2, 2021 Document Security Systems, Inc. DSS or the Company NYSE American:DSS, a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, announced today that its subsidiary, DSS Biomedical International, Inc. DSS Biomedical, completed a 1 million equity investment in Vivacitas Oncology, Inc. Vivacitas, a clinical-stage company focused on difficult-to-treat cancers. We continue to demonstrate our commitment to addressing unmet needs in human healthcare and wellness through key strategic investments, stated Frank D. 